Pancreas: does hyoscyamine butylbromide increase the diagnostic value of helical CT?
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 10207493.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Among 50 patients referred for helical computed tomography (CT) of the pancreas, 24 randomly selected patients received 40 mg of hyoscyamine butylbromide to evaluate whether its administration improved image quality and diagnostic findings. Differences between the groups were not statistically significant. It was therefore concluded that hyoscyamine butylbromide does not contribute a diagnostic advantage at helical CT of the pancreas.
Medical subject headings
- Butylscopolammonium Bromide
- Muscarinic Antagonists
- Pancreas
- Radiographic Image Enhancement
- Tomography, X-Ray Computed